home

Company Snapshot

Read it, Learn it and Do it for your investment Needs
Daily market Tracker
Company News Details
Glenmark Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code: 532296 NSE Symbol: GLENMARK P/E : 48.66
ISIN Demat: INE935A01035 Div & Yield %: 0.2 EPS : 51.73
Book Value: 855.71 Market Cap (Rs. Cr.): 71,047.24 Face Value : 1
Glenmark USA launches Olanzapine for Injection Back
(06 Jul 2026)

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Olanzapine for Injection, 10 mg/vial, Single-Dose Vial. Glenmark's Olanzapine for Injection is bioequivalent and therapeutically equivalent to the reference listed drug, Zyprexa®2 IntraMuscular Injection 10 mg/vial, of Cheplapharm Registration GmbH [NDA 021253].

According to IQVIA® sales data for the 12-month period ending May 2026, the Zyprexa® IntraMuscular Injection market achieved annual sales of approximately $25.4 million.